Thermal Spa Programme for Knee Osteoarthritis, 3-Week Study (NCT07534189)
Summary
The NIH ClinicalTrials.gov registry has registered a prospective cohort study (NCT07534189) evaluating a 3-week thermal spa treatment programme for patients with symptomatic knee osteoarthritis. The study will assess knee joint movement using wearable inertial sensors (Xsens), along with secondary outcomes including pain, physical function, quality of life, and blood transcriptomic profiles. Participants will be evaluated at baseline, post-treatment, and at 3- and 12-month follow-up visits.
What changed
The NIH registered a new prospective cohort study (NCT07534189) on ClinicalTrials.gov examining the effects of a 3-week thermal spa programme on knee osteoarthritis symptoms. The study will use Xsens wearable inertial sensors to measure knee movement fluidity and gait parameters, with additional assessments of pain, physical function, quality of life, and blood transcriptomic profiles at baseline, post-treatment, and 3- and 12-month follow-ups.
For compliance professionals and clinical operations teams, this registration represents an informational record of an upcoming human subjects research study in the US involving medical device sensors. Researchers and institutional review boards may reference this registration for study coordination, while healthcare providers interested in thermal spa interventions for musculoskeletal conditions may monitor outcomes for future clinical applicability.
Archived snapshot
Apr 16, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis
N/A NCT07534189 Kind: NA Apr 16, 2026
Abstract
This study evaluates the effects of a 3-week thermal spa treatment on knee joint movement in patients with knee osteoarthritis. Knee movement fluidity and gait parameters will be analyzed during standardized tasks using wearable inertial sensors (Xsens). Secondary outcomes include changes in pain, physical function, physical activity, quality of life, and blood transcriptomic profiles. Assessments will be performed at baseline, after treatment, and at 3- and 12-month follow-up visits.
Conditions: Gonarthrosis
Interventions: X-sens sensor, Transcriptomic, Self-questionnaire
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.